🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07290712
Recruiting Observational

Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region

NCT07290712 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2026-02-04
Last updated
2026-08-25

Condition(s) studied

PICSPICS-F

Study summary

Post-Intensive Care Syndrome (PICS) refers to long-term cognitive, physical, and psychological impairments that can arise after intensive care treatment. These symptoms may begin within 24 hours of ICU admission and persist for years. Affected patients and their families (PICS-F) face significant burdens, with up to 94% of relatives impacted. Given its high prevalence and socioeconomic impact, this prospective registry study aims to identify risk factors and long-term consequences of PICS and PICS-F.

The study consists of six modules, starting with data collection during ICU stays and continuing with follow-ups at various intervals post-discharge (up to five years). The primary goal is to investigate diagnostic and therapeutic strategies, while secondary objectives include identifying risk factors, determining impairment severity, and exploring biological mechanisms. Standardized questionnaires and biological samples (blood) are used for data collection.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with an ICU stay longer than 72 hours will be included Exclusion Criteria: * Age \< 18 years old * Patients who receive end-of-life care at the time of screening

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Medical University of Vienna Vienna State of Vienna Recruiting
Universitätsklinikum Augsburg Augsburg Bavaria Recruiting
Universitätsklinikum Würzburg Würzburg Bavaria Not Yet Recruiting
Charité - Universitätsmedizin Berlin Berlin State of Berlin Recruiting

More Medical University of Vienna trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07290712 on ClinicalTrials.gov ↗ ← All trials in Germany